462 related articles for article (PubMed ID: 32992917)
1. Regulation of Expression and Latency in BLV and HTLV.
Pluta A; Jaworski JP; Douville RN
Viruses; 2020 Sep; 12(10):. PubMed ID: 32992917
[No Abstract] [Full Text] [Related]
2. Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5' long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency.
Calomme C; Dekoninck A; Nizet S; Adam E; Nguyên TL; Van Den Broeke A; Willems L; Kettmann R; Burny A; Van Lint C
J Virol; 2004 Dec; 78(24):13848-64. PubMed ID: 15564493
[TBL] [Abstract][Full Text] [Related]
3. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
[TBL] [Abstract][Full Text] [Related]
4. Silencers of HTLV-1 and HTLV-2: the pX-encoded latency-maintenance factors.
Harrod R
Retrovirology; 2019 Sep; 16(1):25. PubMed ID: 31492165
[TBL] [Abstract][Full Text] [Related]
5. Animal models of bovine leukemia virus and human T-lymphotrophic virus type-1: insights in transmission and pathogenesis.
Lairmore MD
Annu Rev Anim Biosci; 2014 Feb; 2():189-208. PubMed ID: 25384140
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus.
Miyazato P; Matsuo M; Katsuya H; Satou Y
Viruses; 2016 Jun; 8(6):. PubMed ID: 27322309
[TBL] [Abstract][Full Text] [Related]
7. Characterization of novel Bovine Leukemia Virus (BLV) antisense transcripts by deep sequencing reveals constitutive expression in tumors and transcriptional interaction with viral microRNAs.
Durkin K; Rosewick N; Artesi M; Hahaut V; Griebel P; Arsic N; Burny A; Georges M; Van den Broeke A
Retrovirology; 2016 May; 13(1):33. PubMed ID: 27141823
[TBL] [Abstract][Full Text] [Related]
8. A complex network of transcription factors and epigenetic regulators involved in bovine leukemia virus transcriptional regulation.
Plant E; Bellefroid M; Van Lint C
Retrovirology; 2023 Jun; 20(1):11. PubMed ID: 37268923
[TBL] [Abstract][Full Text] [Related]
9. The region between amino acids 245 and 265 of the bovine leukemia virus (BLV) tax protein restricts transactivation not only via the BLV enhancer but also via other retrovirus enhancers.
Tajima S; Aida Y
J Virol; 2000 Dec; 74(23):10939-49. PubMed ID: 11069988
[TBL] [Abstract][Full Text] [Related]
10. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
Derse D; Casey JW
Science; 1986 Mar; 231(4744):1437-40. PubMed ID: 3006241
[TBL] [Abstract][Full Text] [Related]
11. Sequence polymorphisms in the long terminal repeat of bovine leukemia virus: evidence for selection pressures in regulatory sequences.
Zhao X; Jimenez C; Sentsui H; Buehring GC
Virus Res; 2007 Mar; 124(1-2):113-24. PubMed ID: 17123656
[TBL] [Abstract][Full Text] [Related]
12. Bovine leukemia virus long terminal repeat variability: identification of single nucleotide polymorphisms in regulatory sequences.
Pluta A; Rola-Łuszczak M; Douville RN; Kuźmak J
Virol J; 2018 Oct; 15(1):165. PubMed ID: 30359262
[TBL] [Abstract][Full Text] [Related]
13. Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence.
Ma G; Yasunaga JI; Shimura K; Takemoto K; Watanabe M; Amano M; Nakata H; Liu B; Zuo X; Matsuoka M
Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33875584
[TBL] [Abstract][Full Text] [Related]
14. Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus proteases.
Sperka T; Miklóssy G; Tie Y; Bagossi P; Zahuczky G; Boross P; Matúz K; Harrison RW; Weber IT; Tözsér J
J Gen Virol; 2007 Jul; 88(Pt 7):2052-2063. PubMed ID: 17554040
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics evaluation of the oncogenic mechanisms of two closely related bovine and human deltaretroviruses: A system biology study.
Ashrafi F; Nassiri M; Javadmanesh A; Rahimi H; Rezaee SA
Microb Pathog; 2020 Feb; 139():103845. PubMed ID: 31698053
[TBL] [Abstract][Full Text] [Related]
16. 5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo.
Koiwa T; Hamano-Usami A; Ishida T; Okayama A; Yamaguchi K; Kamihira S; Watanabe T
J Virol; 2002 Sep; 76(18):9389-97. PubMed ID: 12186921
[TBL] [Abstract][Full Text] [Related]
17. Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long Terminal Repeat 5' Region from Patients with Tropical Spastic Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy and Asymptomatic Carriers.
Rego FF; de Oliveira T; Giovanetti M; Galvão-Castro B; Gonçalves Mde S; Alcantara LC
AIDS Res Hum Retroviruses; 2016 Mar; 32(3):279-83. PubMed ID: 26472535
[TBL] [Abstract][Full Text] [Related]
18. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
19. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms.
Taniguchi Y; Nosaka K; Yasunaga J; Maeda M; Mueller N; Okayama A; Matsuoka M
Retrovirology; 2005 Oct; 2():64. PubMed ID: 16242045
[TBL] [Abstract][Full Text] [Related]
20. Human T-Cell Lymphotropic Virus Type 1 Transactivator Tax Exploits the XPB Subunit of TFIIH during Viral Transcription.
Martella C; Tollenaere AI; Waast L; Lacombe B; Groussaud D; Margottin-Goguet F; Ramirez BC; Pique C
J Virol; 2020 Mar; 94(8):. PubMed ID: 32024775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
